A comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non-Hodgkin's lymphoma
- 1 June 1979
- Vol. 43 (6), 2227-2231
- https://doi.org/10.1002/1097-0142(197906)43:6<2227::aid-cncr2820430611>3.0.co;2-j
Abstract
Thirty-nine untreated patients with either lymphocytic or nodular mixed/nodular histiocytic non-Hodgkin's lymphoma, stage II-IV, were randomized to treatment with total body irradiation (TBI), 100 rads in 10 fractions over 12 days, plus combination chemotherapy with either cyclophosphamide, vincristine and prednisone (CVP) or cyclophosphamide, vincristine, procarbazine and prednisone (C-MOPP) or to treatment with combination chemotherapy (CVP or C-MOPP) alone. Remission rate and duration were comparable for both treatment groups; thus the use of both treatment modalities ab initio provides no therapeutic advantage.This publication has 13 references indexed in Scilit:
- Balloon Occlusion of Segmental Hepatic ArteriesJAMA, 1977
- Successful chemotherapy of advanced non-Hodgkin's lymphoma after relapse following total body irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1977
- Sequential Nonsurgical and Surgical Staging of Non-Hodgkin's LymphomaAnnals of Internal Medicine, 1976
- Total body irradiation (TBI) as primary therapy for advanced lymphosarcomaCancer, 1975
- Combination Chemotherapy of Lymphomas Other Than Hodgkin's DiseaseAnnals of Internal Medicine, 1974
- Remission induction and remission duration with primary radiotherapy in advanced lymphosarcomaCancer, 1972
- Combined cyclophosphamide, vincristine, and prednisone therapy of malignant lymphomaCancer, 1971
- Combination Chemotherapy in the Treatment of Advanced Hodgkin's DiseaseAnnals of Internal Medicine, 1970
- Combination Chemotherapy in Lymphosarcoma and Reticulum Cell SarcomaBlood, 1969
- Evaluation of Fractionated Total-Body Irradiation in Patients with Leukemia and Disseminated LymphomasRadiology, 1966